皮炎方湿敷联合光电疗法治疗湿热壅滞型激素依赖性皮炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R275

基金项目:

温州市科技局项目(Y2023231)


Clinical Study on Combination Use of Wet Compress of Piyan Prescription and Electrophototherapy for Topical Corticosteroid Dependent Dermatitis of Damp-Heat Stagnation Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察皮炎方湿敷联合光电疗法治疗湿热壅滞型激素依赖性皮炎(TCDD) 的临床疗效。 方法:纳入2023年10月—2024年10月在浙江中医药大学附属温州市中医院诊治的144例湿热壅滞型TCDD患 者,使用随机数字表法分为对照组及试验组,每组72例。对照组予光电疗法治疗,试验组施以皮炎方湿敷联 合光电疗法治疗。2组均治疗4周。比较2组临床疗效、主观症状(疼痛、灼热、瘙痒) 评分、客观症状(红 斑、干燥脱屑、毛细血管扩张、皮损面积) 评分、皮肤屏障功能[皮肤角质层含水量、经表皮失水率 (TEWL)]、炎症指标[白细胞介素-4(IL-4)、白细胞介素-6(IL-6)、γ干扰素(IFN-γ)] 及不良反应发生 率。结果:治疗4周后,试验组临床疗效总有效率93.06% (67/72),高于对照组80.56% (58/72)(P<0.05)。 治疗2周后,2组3项主观症状、4项客观症状评分以及TEWL均较治疗前降低(P<0.05),皮肤角质层含水量 均较治疗前增多(P<0.05)。治疗4周后,2组3项主观症状、4项客观症状评分以及TEWL均较治疗2周后降 低(P<0.05),皮肤角质层含水量均较治疗2周后增多(P<0.05)。治疗2周、4周,试验组3项主观症状、4项 客观症状评分以及TEWL均低于同期对照组(P<0.05),皮肤角质层含水量多于同期对照组(P<0.05)。治疗 4周后,2组IL-4、IL-6水平均较治疗前降低(P<0.05),IFN-γ水平均较治疗前升高(P<0.05);试验组IL-4、 IL-6水平均低于对照组(P<0.05),IFN-γ水平高于对照组(P<0.05)。试验组不良反应发生率8.33%(6/72),与 对照组5.56% (4/72) 比较,差异无统计学意义(P>0.05)。结论:皮炎方湿敷联合光电疗法治疗湿热壅滞型 TCDD,对患者的症状和皮肤屏障功能均有改善作用,可抑制炎症反应,且安全性较高。

    Abstract:

    Abstract:Objective:To observe the clinical effect of the combination use of wet compress of Piyan Prescription and electrophototherapy on topical corticosteroid dependent dermatitis(TCDD)of damp-heat stagnation type. Methods: A total of 144 TCDD patients of damp-heat stagnation type who were admitted to the Wenzhou TCM Hospital of Zhejiang Chinese Medical University were enrolled and divided into the control group and the trial group by random number table method,with 72 cases in each group. The control group was treated with electrophototherapy,and the trial group was treated with wet compress of Piyan Prescription combined with electrophototherapy. Both groups were treated for four weeks. The clinical effects,scores of subjective symptoms(pain,burning and itching),scores of objective symptoms (erythema,dry with desquamation,telangiectasia and lesion area),skin barrier function [stratum corneum hydration and transepidermal water loss(TEWL)], inflammation indexes [interleukin-4(IL-4), interleukin-6(IL-6) and interferon-γ(IFN-γ)] and incidence of adverse reactions were compared between the two groups. Results:After four weeks of treatment,the total clinical effective rate was 93.06%(67/72)in the trial group,which was higher than that of 80.56%(58 / 72) in the control group(P<0.05). After two weeks of treatment, the scores of three subjective symptoms and four objective symptoms and TEWL in the two groups were down-regulated when compared with those before treatment(P<0.05), and the stratum corneum hydration was up-regulated when compared with that before treatment(P<0.05). After four weeks of treatment, the scores of three subjective symptoms and four objective symptoms and TEWL in the two groups were decreased when compared with those after two weeks of treatment(P< 0.05),and the stratum corneum hydration was increased when compared with that after two weeks of treatment(P< 0.05). After two and four weeks of treatment,the scores of three subjective symptoms and four objective symptoms and TEWL in the trial group were lower than those at the same period in the control group(P<0.05), and the stratum corneum hydration was higher than that at the same period in the control group(P<0.05). After four weeks of treatment, the levels of IL-4 and IL-6 in the two groups were decreased when compared with those before treatment(P<0.05), and the levels of IFN-γ were increased when compared with those before treatment(P<0.05);the levels of IL-4 and IL-6 in the trial group were lower than those in the control group(P<0.05),and the level of IFN-γ was higher than that in the control group(P<0.05). The incidence of adverse reactions was 8.33%(6/72)in the trial group and 5.56% (4/72)in the control group,there being no significance in the difference(P>0.05). Conclusion:The combination use of wet compress of Piyan Prescription and electrophototherapy can improve the symptoms and skin barrier function of TCDD patients of damp-heat stagnation type,inhibit the inflammatory response with great safety.

    参考文献
    相似文献
    引证文献
引用本文

郑明警,赵东瑞.皮炎方湿敷联合光电疗法治疗湿热壅滞型激素依赖性皮炎临床研究[J].新中医,2025,57(22):94-99

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-11-26
  • 出版日期:
文章二维码